Skip to main content
Clinical Trials/CTRI/2023/10/058245
CTRI/2023/10/058245
Recruiting
Phase 2

A single blind randomized comparative clinical study to evaluate the efficacy of Eranda saptaka kwatha and Rasonadi kwatha in the management of Stabdhata and Ruja associated with Amavatha. - nil

Dr Samprath Nayak0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M069- Rheumatoid arthritis, unspecified
Sponsor
Dr Samprath Nayak
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Samprath Nayak

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of age group above 20 years and below 60 years
  • 2\. Patients diagnosed as Amavata on basis of Classical Lakshanas, specifically considering
  • Stabdhata and Ruja for study.
  • 3\. Patient with controlled systemic diseases.

Exclusion Criteria

  • 1\. Patients below 20 years and above 60 years.
  • 2\. Other complicated joint disorders.
  • 3\. Complications including deformities, contractures and nodules.
  • 4\. Other serious systemic complicated disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials